Ludovic Doucet

Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma

Charlotte Domblides, Karen Leroy, I. Monnet et al. · Journal of Thoracic Oncology · 2020 · 133 citations · Full text

Medicine, Immune Checkpoint Inhibitors, Immunology +4

Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis

Paolo Grassi, Ludovic Doucet, Palma Giglione et al. · PLoS ONE · 2016 · 73 citations · Full text

KRYSTAL-12: Phase 3 study of adagrasib versus docetaxel in patients with previously treated advanced/metastatic non-small cell lung cancer (NSCLC) harboring a KRAS^G12C mutation.

Tony Mok, Wenxiu Yao, M. Duruisseaux et al. · Journal of Clinical Oncology · 2024 · 64 citations

Primary Endpoint, Metastatic Nsclc, Pathology +19

MET Exon 14 Alterations and New Resistance Mutations to Tyrosine Kinase Inhibitors: Risk of Inadequate Detection with Current Amplicon-Based NGS Panels

Brigitte Poirot, Ludovic Doucet, Shirine Benhenda et al. · Journal of Thoracic Oncology · 2017 · 59 citations · Full text

New Resistance Mutations, Medicine, Receptor Tyrosine Kinase +8

One-year survival in patients with solid tumours discharged alive from the intensive care unit after unplanned admission: A retrospective study

Édith Borcoman, Axelle Dupont, Éric Mariotte et al. · Journal of Critical Care · 2020 · 45 citations

Palliative Care, Critical Care Management, Critical Care Medicine +10